BG105204A - Salts of paroxetine - Google Patents
Salts of paroxetineInfo
- Publication number
- BG105204A BG105204A BG105204A BG10520401A BG105204A BG 105204 A BG105204 A BG 105204A BG 105204 A BG105204 A BG 105204A BG 10520401 A BG10520401 A BG 10520401A BG 105204 A BG105204 A BG 105204A
- Authority
- BG
- Bulgaria
- Prior art keywords
- paroxetine
- salts
- peperidine
- therapy
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Peperidine compounds, processes for preparing them, pharmaceutical compositions comprising them and their use in therapy are disclosed. 11 claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9814316.7A GB9814316D0 (en) | 1998-07-02 | 1998-07-02 | Novel compounds |
| PCT/EP1999/004543 WO2000001692A1 (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG105204A true BG105204A (en) | 2001-11-30 |
Family
ID=10834803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105204A BG105204A (en) | 1998-07-02 | 2001-01-31 | Salts of paroxetine |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1091958A1 (en) |
| JP (1) | JP2002519421A (en) |
| KR (1) | KR20010053337A (en) |
| CN (1) | CN1314906A (en) |
| AP (1) | AP2000002017A0 (en) |
| AU (2) | AU4903999A (en) |
| BG (1) | BG105204A (en) |
| BR (1) | BR9911679A (en) |
| CA (1) | CA2336470A1 (en) |
| CZ (1) | CZ20004923A3 (en) |
| EA (1) | EA200100098A1 (en) |
| GB (1) | GB9814316D0 (en) |
| HU (1) | HUP0103712A3 (en) |
| ID (1) | ID27766A (en) |
| IL (1) | IL140385A0 (en) |
| NO (1) | NO20006547L (en) |
| PL (1) | PL345365A1 (en) |
| SK (1) | SK20242000A3 (en) |
| TR (1) | TR200100055T2 (en) |
| WO (1) | WO2000001692A1 (en) |
| ZA (2) | ZA992899B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1534305B9 (en) | 2003-05-07 | 2007-03-07 | Osteologix A/S | Treating cartilage / bone conditions with water-soluble strontium salts |
| WO2005082385A1 (en) | 2004-02-26 | 2005-09-09 | Osteologix A/S | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
| EP2266584B1 (en) | 2003-05-07 | 2012-09-05 | Osteologix A/S | Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions |
| AU2005240257B2 (en) | 2004-05-06 | 2011-11-24 | Osteologix A/S | High yield and rapid syntheses methods for producing metallo-organic salts |
| KR100672184B1 (en) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | Paroxetine cholate or cholic acid derivative salts |
| CA2672267C (en) | 2006-07-27 | 2016-05-31 | Emisphere Technologies, Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
| CN109212055B (en) * | 2018-08-19 | 2021-05-07 | 丁立平 | Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water |
| CN109342633B (en) * | 2018-11-27 | 2020-10-02 | 北京市化工职业病防治院 | Method for detecting metabolites of benzene, toluene and xylene in urine |
| CN111337460B (en) * | 2018-12-18 | 2021-09-17 | 中国科学院大连化学物理研究所 | High-stability Halo-tag probe and synthesis and biological application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
| HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
| CA2293247C (en) * | 1997-06-10 | 2005-04-12 | Synthon B.V. | 4-phenylpiperidine compounds |
| IL137684A0 (en) * | 1998-02-06 | 2001-10-31 | Smithkline Beechmam Plc | Salts of paroxetine |
-
1998
- 1998-07-02 GB GBGB9814316.7A patent/GB9814316D0/en not_active Ceased
-
1999
- 1999-04-23 ZA ZA9902899A patent/ZA992899B/en unknown
- 1999-06-30 EA EA200100098A patent/EA200100098A1/en unknown
- 1999-06-30 KR KR1020007015100A patent/KR20010053337A/en not_active Application Discontinuation
- 1999-06-30 CN CN99810197A patent/CN1314906A/en active Pending
- 1999-06-30 PL PL99345365A patent/PL345365A1/en not_active Application Discontinuation
- 1999-06-30 WO PCT/EP1999/004543 patent/WO2000001692A1/en not_active Application Discontinuation
- 1999-06-30 CA CA002336470A patent/CA2336470A1/en not_active Abandoned
- 1999-06-30 AU AU49039/99A patent/AU4903999A/en not_active Abandoned
- 1999-06-30 ID IDW20010252A patent/ID27766A/en unknown
- 1999-06-30 SK SK2024-2000A patent/SK20242000A3/en unknown
- 1999-06-30 AP APAP/P/2000/002017A patent/AP2000002017A0/en unknown
- 1999-06-30 JP JP2000558095A patent/JP2002519421A/en active Pending
- 1999-06-30 EP EP99932772A patent/EP1091958A1/en not_active Withdrawn
- 1999-06-30 IL IL14038599A patent/IL140385A0/en unknown
- 1999-06-30 CZ CZ20004923A patent/CZ20004923A3/en unknown
- 1999-06-30 BR BR9911679-0A patent/BR9911679A/en not_active Application Discontinuation
- 1999-06-30 TR TR2001/00055T patent/TR200100055T2/en unknown
- 1999-06-30 HU HU0103712A patent/HUP0103712A3/en unknown
-
2000
- 2000-12-21 NO NO20006547A patent/NO20006547L/en not_active Application Discontinuation
-
2001
- 2001-01-02 ZA ZA200100020A patent/ZA200100020B/en unknown
- 2001-01-31 BG BG105204A patent/BG105204A/en unknown
- 2001-07-11 AU AU2002100370A patent/AU2002100370A4/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000001692A1 (en) | 2000-01-13 |
| AP2000002017A0 (en) | 2000-12-31 |
| BR9911679A (en) | 2002-01-29 |
| TR200100055T2 (en) | 2001-07-23 |
| ZA992899B (en) | 2000-03-29 |
| EA200100098A1 (en) | 2001-08-27 |
| EP1091958A1 (en) | 2001-04-18 |
| PL345365A1 (en) | 2001-12-17 |
| CN1314906A (en) | 2001-09-26 |
| SK20242000A3 (en) | 2001-07-10 |
| CA2336470A1 (en) | 2000-01-13 |
| ID27766A (en) | 2001-04-26 |
| NO20006547D0 (en) | 2000-12-21 |
| AU4903999A (en) | 2000-01-24 |
| HUP0103712A2 (en) | 2002-05-29 |
| IL140385A0 (en) | 2002-02-10 |
| GB9814316D0 (en) | 1998-09-02 |
| AU2002100370A4 (en) | 2002-06-06 |
| NO20006547L (en) | 2001-02-12 |
| KR20010053337A (en) | 2001-06-25 |
| HUP0103712A3 (en) | 2002-09-30 |
| ZA200100020B (en) | 2002-03-25 |
| CZ20004923A3 (en) | 2001-08-15 |
| JP2002519421A (en) | 2002-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2158778A1 (en) | Paroxetine methanesulfonate | |
| SE9704546D0 (en) | Novel compounds | |
| SE9704545D0 (en) | Novel compounds | |
| SE9704544D0 (en) | Novel compounds | |
| MY125978A (en) | Admantane derivatives | |
| IL125282A (en) | Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases | |
| MX9700082A (en) | Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide. | |
| HUP0204519A3 (en) | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations | |
| IL150201A0 (en) | Novel piperidine and piperazine derivatives | |
| BG64475B1 (en) | Ziprasidone salts | |
| HUP0203902A3 (en) | Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use | |
| IL149154A0 (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same | |
| SE9802937D0 (en) | Novel compounds | |
| HUP0100336A3 (en) | Vla-4 antagonists, pharmaceutical compositions comprising them and process for preparing them | |
| IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
| AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
| BG105204A (en) | Salts of paroxetine | |
| AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
| UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
| EP1059304A4 (en) | Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient | |
| YU46302A (en) | Substituted pyrroles | |
| HUP0200412A2 (en) | New morpholinobenzamide salts, process for their preparation and pharmaceutical compositions containing them and their use | |
| DK1165596T3 (en) | 14,15-alpha-methylene-equilenin derivatives, process for their preparation and drugs containing them | |
| HUP9801085A3 (en) | Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient | |
| HUP0100661A3 (en) | Salts of paroxetine, process for their preparation and medicaments containing the compounds |